Mice Model Market Growth, Size, Trends Analysis - By Mice Type, By Technology, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Mice Model Market Introduction and Overview

According to SPER market research, "Global Mice Model Market Size- By Mice Type, By Technology, By Application, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2034" state that the Global Mice Model Market is predicted to reach 3.29 billion by 2034 with a CAGR of 8.35%.

A mouse model refers to a specific type of laboratory mouse used in scientific and medical research to study human diseases, genetic influences, and various biological mechanisms. These mice are often selectively bred or genetically modified to display certain characteristics or conditions that closely mimic those found in humans. Researchers utilize these models to better understand disease mechanisms, assess the safety and efficacy of new medications, and explore potential treatment strategies.

Restraints: The global market for mice models encounters various constraints that may hinder its expansion. Ethical issues related to animal testing have resulted in strict regulations, which elevate the costs and complexities of compliance for research institutions. Moreover, the limitations in translating findings from mice to human responses present difficulties, particularly in fields such as cancer and neurological research.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Mice Type, By Technology, By Application, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Allentown LLC, Charles River Laboratories International Inc, genOway, Harbour Biomed, Hera Biolabs, Inotiv, Janvier Labs, PolyGene, Taconic Biosciences, Inc, The Jackson Laboratory.

Global Mice Model Market Segmentation:

By Mice Type: Based on the Mice Type, Global Mice Model Market is segmented as; Inbred,

Outbred, Knockout, Hybrid, Other Mice.

By Technology: Based on the Technology, Global Mice Model Market is segmented as; CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies.

By Application: Based on the Application, Global Mice Model Market is segmented as; Research & Development, Production and Quality Control, Academics, Other Applications.

By End User: Based on the End User, Global Mice Model Market is segmented as; Companies, Organisations, Academic and Research Institutes, Contract Research Organizations (CRO).

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25125

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Mice Model Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Mice Model Market

7. Global Mice Model Market, By Mice Type (USD Million) 2021-2034

7.1. Inbred
7.2. Outbred
7.3. Knockout
7.4. Hybrid
7.5. Other Mice

8. Global Mice Model Market, By Technology (USD Million) 2021-2034

8.1. CRISPR
8.2. Microinjection
8.3. Embryonic Stem Cell Injection
8.4. Nuclear Transfer
8.5. Other Technologies

9. Global Mice Model Market, By Application (USD Million) 2021-2034

9.1. Research & Development
- 9.1.1. Infectious Disease
- 9.1.2. Immunological Diseases
- 9.1.3. Cancer
- 9.1.4. Cardiovascular Diseases
- 9.1.5. Diabetes
- 9.1.6. Genetic Diseases
- 9.1.7. Neurological Diseases
- 9.1.8. Other Diseases
9.2. Production and Quality Control
9.3. Academics
9.4. Other Applications

10. Global Mice Model Market, By End User (USD Million) 2021-2034

10.1. Companies
- 10.1.1. Pharmaceutical
- 10.1.2. Biotechnology
- 10.1.3. Cosmetics
- 10.1.4. Other Companies
10.2. Organisations
- 10.2.1. Government
- 10.2.2. Non-government
10.3. Academic and Research Institutes
10.4. Contract Research Organizations (CRO)

11. Global Mice Model Market, By (USD Million) 2021-2034

11.1 Global Mice Model Market Size and Market Share

12. Global Mice Model Market, By Region, (USD Million) 2021-2034

12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America

13. Company Profile

13.1. Allentown LLC
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. Charles River Laboratories International Inc
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. genOway
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Harbour Biomed
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Hera Biolabs
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Inotiv
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. Janvier Labs
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. PolyGene
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Taconic Biosciences, Inc
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. The Jackson Laboratory
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
13.11. Others